A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

NCT03826641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HCP1805
DRUG: HCP1801

Sponsor

Hanmi Pharmaceutical Company Limited